Background and methods. To characterize the abnormalities of lipoprotein composition in patients with chronic renal failure (CRF), the lipid and apolipoprotein (apo) concentrations and composition of major lipoprotein density classes were determined in 20 subjects with moderate to advanced renal failure (GFR 5-59 ml/min) and nine controls. Patients were divided into 14 normotriglyceridaemic (NTG) subjects with triglyceride (TG) levels < 1.7 mmol/1 (150 mg/dl) and six hypertriglyceridaemic (HTG) subjects with TĜ 1.7 mmol/1. Lipoproteins were isolated by preparative ultracentrifugation: very low density (VLDL), intermediate density (IDL), low density (LDL) and high density (HDL) lipoproteins. Results. Although all density classes were characterized by abnormal concentration and composition of some lipid and apo constituents, the most profound changes occurred in IDL and HDL. Cholesterol levels were elevated in VLDL and IDL with little change in LDL and reduced in HDL. TG levels were increased in all density classes. ApoB levels were increased in VLDL, IDL and LDL of all CRF patients reaching the significance levels in VLDL and IDL of HTG (P<0.0l). In IDL, the levels of apoC-peptides and apoE were increased (P<0.01). ApoC-peptides and apo E were also elevated in VLDL of NTG and HTG, but their increase was only significant in HTG (P<0.01). In LDL, the concentration of apoC-II and apoC-III was significantly increased (P<0.05). However, in HDL there was significant (P<0.01) reduction of apoA-I, apoA-II and apoC-peptides in both patient groups. The major compositional change was a significant increase in the relative contents of apoC-II and apoC-III in VLDL, IDL and LDL (P<0.01). Conclusions. Results indicate that the characteristic feature of dyslipoproteinemia in CRF is the accumulation of partially delipidized TG-rich apoB-containing lipoproteins enriched in apoC-peptides and distributed characteristically in the IDL density-range irrespective
Introduction
Chronic renal failure (CRF) is characterized by specific compositional and metabolic abnormalities of plasma lipoproteins [1] . The renal dyslipoproteinaemia may be manifested by elevated plasma lipid concentrations. However, specific compositional alterations of lipoproteins can also be detected in normolipidaemic patients as reflected by abnormal concentration and composition of apolipoproteins [2] . We have earlier shown that this dyslipoproteinaemic condition is present not only in advanced renal failure and during dialysis but also in asymptomatic earlier stages of renal insufficiency when the glomerular filtration rate (GFR) is reduced below 50 ml/min [2] [3] [4] . The characteristic plasma apolipoprotein abnormalities include increased concentrations of apolipoprotein (apo) B and apoCpeptides and decreased concentrations of apoA-I and apoA-II [4, 5] . The purpose of the present study was to further explore the altered lipoprotein composition in patients with both moderate and advanced renal failure. The specific aim was to determine the abnormalities in the lipid and apolipoprotein concentrations of major lipoprotein density classes in these patients. A further objective was to investigate whether these abnormalities are found both in normolipidaemic and hyperlipidaemic patients.
Subjects and methods

Patients
Twenty adult patients (11 men, 9 women, mean age 45.7+13.1 years) with chronic renal insufficiency (GFR 5-59ml/min/1.73 m 2 BSA) were investigated. Clinical characteristics of these patients are presented in Table 1 . For certain analyses the patients were separated into two groups: 14 normotriglyceridaemic (NTG) and six hypertriglyceridaemic (HTG) patients with plasma triglyceride (TG) concentration 1.7 mmol/1 (150mg/dl) as the cut-off point. The patients attended the Department of Nephrology at the Sahlgrenska University Hospital, GSteborg, Sweden. The patients were treated with antihypertensive drugs, diuretics, sodium bicarbonate, and phosphate-binding drugs as appropriate. No patient was treated with corticosteroids, immunosuppressive drugs, or drugs known to significantly influence lipoprotein metabolism. The patients received no dietary counselling prior to the study.
Control subjects
Nine healthy, normolipidaemic, Caucasian subjects (4 men, 5 women, age 44.7 ± 17.0 years), employees of University of GSteborg and Oklahoma Medical Research Foundation, served as controls.
Methodology
Blood samples were obtained from antecubital venepuncture after an overnight fast. Plasma samples contained EDTA (1 mg/ml) and e-aminocaproic acid (1.3 mg/ml) as preservatives. Samples were immediately shipped by air freight to
Oklahoma City for analysis within 3-4 days of sampling. Lipoprotein density classes were isolated by sequential preparative ultracentrifugation using Quick-Seal tubes (Beckman, Palo Alto, CA) by a previous described procedure [6] . The very low density lipoproteins (VLDL, d< 1.006 g/ml), intermediate density lipoproteins (IDL, d 1.006-1.019 g/ml), low density lipoproteins (LDL, d 1.019-1.063 g/ml) and high density lipoproteins (HDL, d 1.063-1.21 g/ml) were isolated at solution densities 1.006 g/ml, 1.019 g/ml, 1.063 g/ml and 1.21 g/ml respectively. All lipoprotein density classes were dialysed against 0.15 M NaCl containing 0.05% EDTA (pH 7.0). The recovery of lipids ranged between 85 and 95% of plasma values and that of apolipoproteins ranged between 75 and 80% for apoCpeptides and 80 and 90% for apolipoproteins A-I, A-H, B, and E. Lipid and apolipoprotein values of VLDL, IDL, LDL, and HDL were adjusted to those of whole plasma.
Total cholesterol (TC) and TG contents were determined by enzymatic methods as previously described [7] . The percentage composition of cholesterol esters (CE), free cholesterol (FC), and TG in lipoprotein density classes was determined by gas chromatography [8] .
Concentrations of apolipoproteins A-I, A-H, B, C-I, C-II, C-III, and E were measured by electroimmunoassays as previously described [5, 6, 9] . The isolation of antigens and the preparation of monospecific antisera were described in detail and reported in several publications from this laboratory [5, 6, 9] .
The lipid mass refers to the sum of individually determined total cholesterol and triglyceride concentrations and apolipoprotein mass to the sum of individually determined levels of apolipoproteins A-I, A-H, B, C-L C-II, C-III, and E in each of the major lipoprotein density classes.
Statistical methods
Conventional statistical methods were used to describe the salient features of the results. Student's unpaired two-tailed t test was used to test the significance of differences between means.
Results
Plasma lipid and apolipoprotein concentrations
Plasma TG concentrations, but not TC concentrations, were significantly increased in the CRF patients (Table 2 ) and were significantly correlated to GFR values (r= -0 . 4 5 , P<0.05). In the NTG patients there was a slight increase in the levels of TG compared to control subjects. However, in HTG patients there was a nearly threefold increase of plasma TG and an increase of plasma TC levels. Apolipoproteins A-I and A-II were significantly reduced in both NTG and HTG patients. ApoB concentrations were significantly elevated only in the HTG patients, whereas a significant increase in apoC-III levels was found in all CRF patients. In addition the HTG patients had increased concentrations of apoC-I and apoC-II, but no change in the concentration of apoE. Consequently, the apoA-I/apoC-III ratio and the apoA-I/apoB were significantly reduced in all CRF patients together with a significantly increased apoC-III/apoE ratio. '5. 
Lipid and apolipoprotein concentrations in lipoprotein density classes
Although the concentrations of lipids and apolipoproteins B, C-I, C-II, C-III, and E in VLDL were higher in the patient group than in controls, the statistically significant increases were only reached in HTG patients (Table 3) . However, the differences in the levels of lipids and apolipoproteins between CRF patients and controls were expressed more significantly in IDL than VLDL. Significantly higher levels of TC, apoC-peptides and apoE were observed in the entire patient population as well as in NTG and HTG patients ( Table 3 ). The TG levels were also increased in all patient groups. The apoB concentrations were significantly higher in the entire patient group and HTG patients. There were no differences in the levels of apoA-I and apoA-II between patients and controls. In LDL, the most characteristic differences between patient groups and controls included significantly increased concentrations of TG, apoC-II and apoC-III (Table 3 ). In contrast, the concentrations of apoB and apoE were similar in patients and controls. The levels of apoA-I and apoA-II were lower in patients than controls. In HDL of all patient groups, there were significant decreases in the concentrations of apoA-I, apoA-II, apoC-I and apoC-II and increases in the levels of apoB (Table 3) . Decreased levels of TC were statistically significant in the entire patient population and HTG patients. The apoC-III and apoE concentrations were slightly decreased and the TG concentrations were slightly increased in all patient groups in comparison with controls.
The differences in the lipid and apolipoprotein concentrations between CRF patients and controls were clearly reflected in the lipid and apolipoprotein masses of their corresponding lipoprotein density classes ( Figure 1 ). The most affected lipoprotein density classes of CRF patients were IDL and HDL. In comparison with normal controls, CRF patients were characterized by a significant twofold increase in the total lipoprotein mass of IDL (77.5 ±52.3 vs 34.6 + 20.8 mg/dl; / ) <0.05) and a significant reduction of that of HDL (217.5±55.9 vs 320.1 ±60.4; P<0.001). Significantly increased levels of apolipoprotein masses of IDL and reduced apolipoprotein masses of HDL were characteristic of both NTG and HTG patients. Although the lipid and apolipoprotein masses of VLDL and LDL were elevated in CRF patients when compared to controls, the statistical significance was only reached in HTG patients. The proportional increase of apolipoprotein mass in IDL and decrease in HDL were greater than those of lipid mass in both NTG and HTG patients.
Distribution of lipids and apolipoproteins in lipoprotein density classes
Changes in the apolipoprotein mass of lipoprotein density classes in CRF patients are closely associated with the redistribution of apolipoproteins B, C and E between HDL and IDL and LDL. In CRF patients, tion of apoE. In contrast, the percentage distribution of total apoC-peptides and apoE in HDL of CRF patients was significantly reduced (40-60%, P<0.01-P<0.001). The changes in the percentage distribution of total TG, TC, apoA-I and apoA-H were non-significant.
The altered distribution of apoC-III among major lipoprotein density classes of CRF patients is illustrated in Figure 2 . The significantly increased concentration of apoC-III in whole plasma is reflected in increases of apoC-III in VLDL, IDL, and LDL but not HDL. Plasma concentration of apoC-III was significantly correlated with IDL-apoC-III (r = 0.72, P<0.0l) and LDL-apoC-III (r = 0.48, P<0.05). The proportionally greater increase of apoC-III than those of apoB and apoE was found in all density classes of CRF patients. The apoC-III/apoE ratio was increased more than twofold in IDL and 3-5-fold in LDL. Furthermore, there were significant decreases of apoB/apoC-III and apoB/apoE ratios in VLDL and IDL.
Composition oflipids and apolipoproteins in lipoprotein density classes
The most characteristic compositional differences in VLDL, IDL and LDL between CRF patients and controls relate to the relative contents of cholesterol esters, TG and apolipoproteins C-II and C-III. In VLDL, CRF patients had a significantly higher percentage of cholesterol esters (36.4 There was no significant difference in the apolipoprotein composition of VLDL between patients and controls, although the relative contents of apolipoproteins B, C-III and E tended to be slightly higher in the former than in the latter subjects. However, in IDL of CRF patients the percentages of apoC-II (3.3 ± 1.6 vs 1.3±1.1%; P<0.01) and apoC-III (13.3±5.3 vs 5.6 ±2.4%; P< 0.001) were significantly higher than in controls with insignificant changes in the relative contents of other apolipoproteins; these compositional differences occurred in both NTG and HTG patients. The LDL composition of CRF patients was also characterized by significantly higher percentages of apoC-I (2.8 + 1.8 vs 1.3±0.8%; / ) <0.05), apoC-II 1.3 ±0.6 vs 0.5 ±0.2%; / > <0.01) and apoC-III (6.1 ±3.0 vs 2.1 + 1.0%; P< 0.001) than that of control subjects. As in IDL, these differences were observed in both NTG and HTG patients. There were no significant differences in the proportions of LDL-apoB and apoE between patients and controls.
The neutral lipid composition of HDL did not differ between patients and controls. Both the NTG and HTG patients had significantly reduced relative contents of apoA-I (59.6±4.9 and 57.5 +10.1 vs 66.3 + 3.3%; P<0.01 and P<0.05 respectively) and increased percentages of apoA-II (28.9 ±4.1 and 31.3 ±9.7 vs 24.3 ±2.4%; / > <0.05) and apoB (3.4±2.1 and 4.8 ±2.6 vs 0.8 ±1.4%; / > <0.01). However, there were no compositional differences in apoC-peptides and apoE between patients and controls.
Discussion
Results of this study have shown that each of the major lipoprotein density classes from predialysis patients with CRF is characterized by abnormal concentration, distribution, and composition of at least some lipid and apolipoprotein constituents. By including both the lipid and apolipoprotein measurements, this study extends previous observations which had been mainly concerned with the abnormal lipid profiles of lipoprotein density classes in CRF patients on maintenance haemodialysis [10] [11] [12] . Present findings have demonstrated that lipid abnormalities of lipoprotein density classes from predialysis CRF patients are very similar to those found in dialysed patients. Additionally, they have established that altered apolipoprotein concentration profiles of lipoprotein density classes are characteristic of predialytic CRF patients irrespective of their plasma lipid concentrations [2, 4] . Because of a negative correlation between GFR values and TG values, one may conclude that patients with advanced renal failure resemble more closely hypertriglyceridaemic than normotriglycerida-emic patients regarding their levels of lipids and apolipoproteins in density classes and vice versa.
It appears that one of the main underlying reasons for the composition abberation of all lipoprotein density classes in CRF patients is the accumulation of complex apoB-containing lipoproteins partially depleted of TG and enriched with cholesterol esters, apoC-peptides and apoE [13, 14] . This occurs in HTG patients in an exaggerated form. Although present to varying extent in VLDL and LDL, these complex apoB-containing lipoproteins accumulate mainly in the IDL density range (Table 3 ; Figure 1 ) [12, [15] [16] [17] [18] [19] [20] . The most characteristic compositional feature of these lipoproteins is that their relative and absolute contents of apoC-III are greater than those of apoC-I, apoC-II and apoE in NTG and, especially, HTG patients (Table 3 ; Figure 2) . It is quite possible that this compositional abnormality is mainly responsible for the increased prevalence of the so-called late pre-beta or broad-beta lipoproteins in the electrophoretic pattern of normo-and hypertriglyceridaemic CRF patients [15, 17, 18, 21] .
Results from this and other laboratories have established that major lipoprotein density classes do not consist of chemically and metabolically homogeneous lipid-protein complexes, but represent mixtures of polydisperse lipoprotein families of particles characterized by similar density properties but distinct apolipoprotein composition [22] . The determination of apoBcontaining lipoprotein families in whole plasma and VLDL, IDL, and LDL of predialysis patients with CRF has shown that in comparison with controls the increased concentration and abnormal composition of apoB-containing lipoproteins are mainly due to elevated levels of triglyceride-rich lipoprotein B:C (LP-B:C) and lipoprotein B:C:E (LP-B:C:E) with no significant change in the levels of cholesterol-rich lipoprotein B (LP-B) [23] .
What are the potential metabolic and pathogenetic consequences of increased concentrations of LP-B:C:E and, especially, LP-B:C particles? It has been shown that LP-B:C and LP-B:C:E particles are efficient substrates for lipoprotein lipase [24] . However, the reduced activities of lipoprotein lipase and hepatic trigJyceride lipase and/or the presence of an inhibitor of lipoprotein lipase in CRF patients may trigger an inefficient lipolytic degradation of LP-B:C and LP-B:C:E particles and cause their accumulation in partially delipidized form [ 1 ] . Partial or total inhibition of LP-B:C:E and LP-B:C binding and uptake by LDL receptor [25] may further contribute to their accumulation in circulation. These metabolic abnormalities may be attributed to the increased concentrations of apoC-III shown to be a potential inhibitor of both lipoprotein lipase activity [26] and lipoprotein binding to LDL receptor [25, 27] . ApoE on the other hand promotes the hepatic uptake of TG-rich lipoproteins (27) . The increased apoC-III:E ratios in CRF patients indicate the extent of the inhibition of TG-rich lipoprotein uptake. However, such lipoprotein particles may bind to macrophages by receptors distinct from the LDL P.-O. Attman et al. receptor [28] . There is increasing evidence from clinical trials [29] [30] [31] [32] [33] [34] suggesting that partially delipidized triglyceride-rich lipoproteins ('remnant lipoproteins') may have atherogenic potential equal to or greater than that of cholesterol-rich lipoproteins. Thus, increased concentrations of apoC-III-enriched lipoproteins of IDL size may be considered as a significant risk factor for coronary artery disease so prevalent in CRF patients. Moreover there is some evidence that increased concentrations of these lipoprotein particles may also contribute to the progression of renal insufficiency [35] .
Reduced concentrations of apoA-I and apoA-II may be either a consequence of abnormal accumulation of partially delipidized complex apoB-containing lipoproteins and/or a separate metabolic abberation [12, 27] . Recent findings suggest that the reduced levels of these two apolipoproteins are caused by reduced formation of lipoprotein A-LA-II (LP-A-LA-II) rather than lipoprotein A-I (LP-A-I) [36] . Increased concentration of apoB in HDL may be due either to elevated levels of LP-B particles of higher density and/or lipoprotein (a) previously reported to be increased in patients with CRF [13, 37] .
In summary, the lipid transport in CRF is characterized by abnormalities in the metabolism of triglyceriderich lipoproteins of lower densities and of HDL, both of which may be manifested at the early stages of renal insufficiency and may not be reflected in elevated plasma lipid concentrations. There is some indication that the former abnormality may be due to the accumulation of a partially metabolized TG-rich lipoprotein of hepatic and/or intestinal origin (remnant lipoprotein), the structural make-up of which prevents its normal degradation and removal but presumably enhances its atherogenic potential. The nature and significance of the metabolic abnormality of HDL remains obscure except for the generalization that reduced concentration of these lipoprotein particles reduce their non-atherogenic capacity. The prognostic significance of these metabolic abnormalities and their effect on progression of renal disease and its vascular manifestations remain to be explored.
